%0 Journal Article
%T The effect of polyclonal and monoclonal based antibodies as promising potential therapy for treatment of sepsis: A systematic review.
%A Mahdizade Ari M
%A Amini ME
%A Sholeh M
%A Zahedi Bialvaei A
%J New Microbes New Infect
%V 60
%N 0
%D 2024 Aug-Oct
%M 38860003
暂无%R 10.1016/j.nmni.2024.101435
%X While mortality caused by sepsis remains an unsolved problem, studies showed conflicting results about effectiveness of monoclonal and polyclonal antibodies in patients suffering sepsis. For this reason, this current study provides an update of review clinical randomized trial studies until March 2024. The main object of this study is to determine effects of monoclonal and polyclonal antibodies on mortality rate and hospitalization of patients suffering sepsis. Search of Scopus, Web of science, EMBASE, PubMed and Cochrane were performed and randomized controlled trials which conducted in patients with septic shock or bacterial sepsis were included. Two reviewers assessed all searched trials for eligibility according to already defined criteria and did data collection and analyses afterwards. Present study showed monoclonal and polyclonal antibodies are a safe strategy with mild-to-moderate adverse effects. However, most studies indicate no significant change among inter-and intra-group comparison (p > 0.05) and further studies are needed, results showed an increase in survival rate, ventilator-and ICU-free days, resolve organ dysfunction, mediating inflammation related cytokines.